
Health
Beyond Weight Loss: What the WHO's Latest Reviews Reveal About GLP-1 Drugs
Three WHO-commissioned systematic reviews analyzed GLP-1 drugs across 44,000+ participants. The findings go well beyond the scale. Here's what matters.
Dash Hartwell·

Three WHO-commissioned systematic reviews analyzed GLP-1 drugs across 44,000+ participants. The findings go well beyond the scale. Here's what matters.

GLP-1 medications like Ozempic increase muscle loss risk. Learn the protein timing strategy that protects lean mass while maximizing fat loss.

From next-generation GLP-1 medications to continuous glucose monitors and AI apps, discover the science-backed technologies reshaping weight management in 2025.

GLP-1 agonists like Ozempic reduce appetite dramatically, but without proper nutrition, muscle loss and deficiencies follow.

From personalized nutrition stacks to GLP-1 support formulas, discover which 2025 supplement trends have real science behind them and which are just marketing.